{"transactions":[{"id":3201584,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":150481,"kind":"person","name":"Griffin Deborah A","position":1,"cik":"0001719115","reported_name":"Griffin Deborah A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Share Units","published_at":"2020-03-19T12:09:19.000Z","date":"2020-03-17","kind":"exercise","acquired":false,"shares":944,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted share units were granted on March 17, 2016, with 943 vesting on each of March 17, 2018 and March 17, 2019 and 944 vesting on March 17, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted share units were granted on March 17, 2016, with 943 vesting on each of March 17, 2018 and March 17, 2019 and 944 vesting on March 17, 2020."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":944},"source":{"system":"sec-edgar","filing":"0001209191-20-020167","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120020167/doc4.xml","form_type":"4"}},{"id":3201583,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":150481,"kind":"person","name":"Griffin Deborah A","position":1,"cik":"0001719115","reported_name":"Griffin Deborah A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2020-03-19T12:09:19.000Z","date":"2020-03-17","kind":"sale","acquired":false,"shares":944,"price":7.1635,"value":6762.344,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.1600 to $7.1850, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-020167","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120020167/doc4.xml","form_type":"4"}},{"id":3201582,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":150481,"kind":"person","name":"Griffin Deborah A","position":1,"cik":"0001719115","reported_name":"Griffin Deborah A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2020-03-19T12:09:19.000Z","date":"2020-03-17","kind":"exercise","acquired":true,"shares":944,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":944,"source":{"system":"sec-edgar","filing":"0001209191-20-020167","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120020167/doc4.xml","form_type":"4"}},{"id":3225623,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":150481,"kind":"person","name":"Griffin Deborah A","position":1,"cik":"0001719115","reported_name":"Griffin Deborah A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Share Units","published_at":"2020-03-05T13:16:08.000Z","date":"2020-03-04","kind":"exercise","acquired":false,"shares":4807,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted share units were granted on March 4, 2019, with 4,807 vesting on each of March 4, 2020, March 4, 2021 and March 4, 2022 and 4,810 vesting on March 4, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted share units were granted on March 4, 2019, with 4,807 vesting on each of March 4, 2020, March 4, 2021 and March 4, 2022 and 4,810 vesting on March 4, 2023."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":14424,"derivative":{"underlying":"Ordinary Shares","underlying_shares":4807},"source":{"system":"sec-edgar","filing":"0001209191-20-016462","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120016462/doc4.xml","form_type":"4"}},{"id":3225622,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":150481,"kind":"person","name":"Griffin Deborah A","position":1,"cik":"0001719115","reported_name":"Griffin Deborah A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2020-03-05T13:16:08.000Z","date":"2020-03-04","kind":"sale","acquired":false,"shares":4807,"price":11.2294,"value":53979.7258,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.0900 to $11.3800, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-016462","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120016462/doc4.xml","form_type":"4"}},{"id":3225621,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":150481,"kind":"person","name":"Griffin Deborah A","position":1,"cik":"0001719115","reported_name":"Griffin Deborah A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2020-03-05T13:16:08.000Z","date":"2020-03-04","kind":"exercise","acquired":true,"shares":4807,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":4807,"source":{"system":"sec-edgar","filing":"0001209191-20-016462","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120016462/doc4.xml","form_type":"4"}},{"id":3229570,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":150481,"kind":"person","name":"Griffin Deborah A","position":1,"cik":"0001719115","reported_name":"Griffin Deborah A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Share Units","published_at":"2020-03-04T11:39:18.000Z","date":"2020-03-03","kind":"exercise","acquired":false,"shares":1166,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on March 3, 2017, with 1,166 vesting on each of March 3, 2018, March 3, 2019, March 3, 2020 and March\n3, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on March 3, 2017, with 1,166 vesting on each of March 3, 2018, March 3, 2019, March 3, 2020 and March\n3, 2021."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":1166,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1166},"source":{"system":"sec-edgar","filing":"0001209191-20-015874","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120015874/doc4.xml","form_type":"4"}},{"id":3229569,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":150481,"kind":"person","name":"Griffin Deborah A","position":1,"cik":"0001719115","reported_name":"Griffin Deborah A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Share Units","published_at":"2020-03-04T11:39:18.000Z","date":"2020-03-02","kind":"exercise","acquired":false,"shares":2941,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Restricted share units were granted on March 2, 2018, with 2,941 vesting on each of March 2, 2019, March 2, 2020, March 2, 2021 and March\n2, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Restricted share units were granted on March 2, 2018, with 2,941 vesting on each of March 2, 2019, March 2, 2020, March 2, 2021 and March\n2, 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":5882,"derivative":{"underlying":"Ordinary Shares","underlying_shares":2941},"source":{"system":"sec-edgar","filing":"0001209191-20-015874","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120015874/doc4.xml","form_type":"4"}},{"id":3229568,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":150481,"kind":"person","name":"Griffin Deborah A","position":1,"cik":"0001719115","reported_name":"Griffin Deborah A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2020-03-04T11:39:18.000Z","date":"2020-03-03","kind":"sale","acquired":false,"shares":1166,"price":11.3658,"value":13252.5228,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.8900 to $11.7400, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-015874","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120015874/doc4.xml","form_type":"4"}},{"id":3229567,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":150481,"kind":"person","name":"Griffin Deborah A","position":1,"cik":"0001719115","reported_name":"Griffin Deborah A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2020-03-04T11:39:18.000Z","date":"2020-03-03","kind":"exercise","acquired":true,"shares":1166,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":1166,"source":{"system":"sec-edgar","filing":"0001209191-20-015874","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120015874/doc4.xml","form_type":"4"}},{"id":3229566,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":150481,"kind":"person","name":"Griffin Deborah A","position":1,"cik":"0001719115","reported_name":"Griffin Deborah A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2020-03-04T11:39:18.000Z","date":"2020-03-02","kind":"sale","acquired":false,"shares":2941,"price":11.5989,"value":34112.3649,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.4600 to $11.7300, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-015874","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120015874/doc4.xml","form_type":"4"}},{"id":3229565,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":150481,"kind":"person","name":"Griffin Deborah A","position":1,"cik":"0001719115","reported_name":"Griffin Deborah A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2020-03-04T11:39:18.000Z","date":"2020-03-02","kind":"exercise","acquired":true,"shares":2941,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":2941,"source":{"system":"sec-edgar","filing":"0001209191-20-015874","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120015874/doc4.xml","form_type":"4"}},{"id":3235426,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":150481,"kind":"person","name":"Griffin Deborah A","position":1,"cik":"0001719115","reported_name":"Griffin Deborah A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Share Units","published_at":"2020-03-03T12:12:55.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":21459,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on February 28, 2020 with 5,364 vesting on each of February 28, 2021, February 28, 2022 and February 28, 2023 and 5,367 vesting on February 28, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on February 28, 2020 with 5,364 vesting on each of February 28, 2021, February 28, 2022 and February 28, 2023 and 5,367 vesting on February 28, 2024."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":21459,"derivative":{"underlying":"Ordinary Shares","underlying_shares":21459},"source":{"system":"sec-edgar","filing":"0001209191-20-014850","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120014850/doc4.xml","form_type":"4"}},{"id":3409352,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":150481,"kind":"person","name":"Griffin Deborah A","position":1,"cik":"0001719115","reported_name":"Griffin Deborah A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Share Units","published_at":"2019-09-20T11:12:17.000Z","date":"2019-09-18","kind":"exercise","acquired":false,"shares":2376,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted share units were granted on September 18, 2017, with 2,376 vesting on each of September 18, 2018 and September 18, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted share units were granted on September 18, 2017, with 2,376 vesting on each of September 18, 2018 and September 18, 2019."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":2376},"source":{"system":"sec-edgar","filing":"0001209191-19-050263","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119050263/doc4.xml","form_type":"4"}},{"id":3409351,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":150481,"kind":"person","name":"Griffin Deborah A","position":1,"cik":"0001719115","reported_name":"Griffin Deborah A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2019-09-20T11:12:17.000Z","date":"2019-09-18","kind":"sale","acquired":false,"shares":2376,"price":7.8313,"value":18607.1688,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.82 to $7.835, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-19-050263","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119050263/doc4.xml","form_type":"4"}},{"id":3409350,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":150481,"kind":"person","name":"Griffin Deborah A","position":1,"cik":"0001719115","reported_name":"Griffin Deborah A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2019-09-20T11:12:17.000Z","date":"2019-09-18","kind":"exercise","acquired":true,"shares":2376,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":2376,"source":{"system":"sec-edgar","filing":"0001209191-19-050263","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119050263/doc4.xml","form_type":"4"}},{"id":3589262,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":150481,"kind":"person","name":"Griffin Deborah A","position":1,"cik":"0001719115","reported_name":"Griffin Deborah A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Share Units","published_at":"2019-03-19T12:06:49.000Z","date":"2019-03-17","kind":"exercise","acquired":false,"shares":943,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted share units were granted on March 17, 2016, with 943 vesting on each of March 17, 2018 and March 17, 2019 and 944 vesting on March 17, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted share units were granted on March 17, 2016, with 943 vesting on each of March 17, 2018 and March 17, 2019 and 944 vesting on March 17, 2020."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":944,"derivative":{"underlying":"Ordinary Shares","underlying_shares":943},"source":{"system":"sec-edgar","filing":"0001209191-19-020158","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119020158/doc4.xml","form_type":"4"}},{"id":3589261,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":150481,"kind":"person","name":"Griffin Deborah A","position":1,"cik":"0001719115","reported_name":"Griffin Deborah A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2019-03-19T12:06:49.000Z","date":"2019-03-18","kind":"sale","acquired":false,"shares":943,"price":16.6251,"value":15677.4693,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.5800 to $16.6800, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-19-020158","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119020158/doc4.xml","form_type":"4"}},{"id":3589260,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":150481,"kind":"person","name":"Griffin Deborah A","position":1,"cik":"0001719115","reported_name":"Griffin Deborah A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2019-03-19T12:06:49.000Z","date":"2019-03-17","kind":"exercise","acquired":true,"shares":943,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":943,"source":{"system":"sec-edgar","filing":"0001209191-19-020158","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119020158/doc4.xml","form_type":"4"}},{"id":3596252,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":150481,"kind":"person","name":"Griffin Deborah A","position":1,"cik":"0001719115","reported_name":"Griffin Deborah A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Share Units","published_at":"2019-03-14T11:33:37.000Z","date":"2019-03-12","kind":"exercise","acquired":false,"shares":953,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted share units were granted on March 12, 2015, with 952 vesting on March 12, 2018 and 953 vesting on March 12, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted share units were granted on March 12, 2015, with 952 vesting on March 12, 2018 and 953 vesting on March 12, 2019."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":953},"source":{"system":"sec-edgar","filing":"0001209191-19-019328","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119019328/doc4.xml","form_type":"4"}},{"id":3596251,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":150481,"kind":"person","name":"Griffin Deborah A","position":1,"cik":"0001719115","reported_name":"Griffin Deborah A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2019-03-14T11:33:37.000Z","date":"2019-03-12","kind":"sale","acquired":false,"shares":953,"price":15.6749,"value":14938.1797,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.6600 to $15.6911, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-19-019328","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119019328/doc4.xml","form_type":"4"}},{"id":3596250,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":150481,"kind":"person","name":"Griffin Deborah A","position":1,"cik":"0001719115","reported_name":"Griffin Deborah A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2019-03-14T11:33:37.000Z","date":"2019-03-12","kind":"exercise","acquired":true,"shares":953,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":953,"source":{"system":"sec-edgar","filing":"0001209191-19-019328","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119019328/doc4.xml","form_type":"4"}},{"id":3609903,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":150481,"kind":"person","name":"Griffin Deborah A","position":1,"cik":"0001719115","reported_name":"Griffin Deborah A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Share Units","published_at":"2019-03-06T12:15:37.000Z","date":"2019-03-04","kind":"grant","acquired":true,"shares":19321,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on March 4, 2019, with 4,807 vesting on March 4, 2020 and 4,808 vesting on each of March 4, 2021, March 4, 2022 and March 4, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on March 4, 2019, with 4,807 vesting on March 4, 2020 and 4,808 vesting on each of March 4, 2021, March 4, 2022 and March 4, 2023."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":19321,"derivative":{"underlying":"Ordinary Shares","underlying_shares":19321},"source":{"system":"sec-edgar","filing":"0001209191-19-017231","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119017231/doc4.xml","form_type":"4"}},{"id":3616190,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":150481,"kind":"person","name":"Griffin Deborah A","position":1,"cik":"0001719115","reported_name":"Griffin Deborah A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Share Units","published_at":"2019-03-05T12:23:23.000Z","date":"2019-03-02","kind":"exercise","acquired":false,"shares":2941,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Restricted share units were granted on March 2, 2018, with 2,941 vesting on each of March 2, 2019, March 2, 2020, March 2, 2021 and March 2, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Restricted share units were granted on March 2, 2018, with 2,941 vesting on each of March 2, 2019, March 2, 2020, March 2, 2021 and March 2, 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":8823,"derivative":{"underlying":"Ordinary Shares","underlying_shares":2941},"source":{"system":"sec-edgar","filing":"0001209191-19-016087","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119016087/doc4.xml","form_type":"4"}},{"id":3616189,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":150481,"kind":"person","name":"Griffin Deborah A","position":1,"cik":"0001719115","reported_name":"Griffin Deborah A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Share Units","published_at":"2019-03-05T12:23:23.000Z","date":"2019-03-03","kind":"exercise","acquired":false,"shares":1166,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted share units were granted on March 3, 2017, with 1,166 vesting on each of March 3, 2018, March 3, 2019, March 3, 2020 and March 3, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted share units were granted on March 3, 2017, with 1,166 vesting on each of March 3, 2018, March 3, 2019, March 3, 2020 and March 3, 2021."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":2332,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1166},"source":{"system":"sec-edgar","filing":"0001209191-19-016087","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119016087/doc4.xml","form_type":"4"}},{"id":3616188,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":150481,"kind":"person","name":"Griffin Deborah A","position":1,"cik":"0001719115","reported_name":"Griffin Deborah A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2019-03-05T12:23:23.000Z","date":"2019-03-04","kind":"sale","acquired":false,"shares":1166,"price":16.8833,"value":19685.9278,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.755 to $17.130, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-19-016087","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119016087/doc4.xml","form_type":"4"}},{"id":3616187,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":150481,"kind":"person","name":"Griffin Deborah A","position":1,"cik":"0001719115","reported_name":"Griffin Deborah A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2019-03-05T12:23:23.000Z","date":"2019-03-04","kind":"sale","acquired":false,"shares":2941,"price":16.8833,"value":49653.7853,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.755 to $17.130, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":1166,"source":{"system":"sec-edgar","filing":"0001209191-19-016087","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119016087/doc4.xml","form_type":"4"}},{"id":3616186,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":150481,"kind":"person","name":"Griffin Deborah A","position":1,"cik":"0001719115","reported_name":"Griffin Deborah A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2019-03-05T12:23:23.000Z","date":"2019-03-03","kind":"exercise","acquired":true,"shares":1166,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":4107,"source":{"system":"sec-edgar","filing":"0001209191-19-016087","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119016087/doc4.xml","form_type":"4"}},{"id":3616185,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":150481,"kind":"person","name":"Griffin Deborah A","position":1,"cik":"0001719115","reported_name":"Griffin Deborah A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2019-03-05T12:23:23.000Z","date":"2019-03-02","kind":"exercise","acquired":true,"shares":2941,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":2941,"source":{"system":"sec-edgar","filing":"0001209191-19-016087","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119016087/doc4.xml","form_type":"4"}},{"id":3795481,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":150481,"kind":"person","name":"Griffin Deborah A","position":1,"cik":"0001719115","reported_name":"Griffin Deborah A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Share Units","published_at":"2018-10-09T20:06:34.000Z","date":"2018-03-02","kind":"grant","acquired":true,"shares":11764,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted share units were granted on March 2, 2018, with 2,941 vesting on each of March 2, 2019, March 2, 2020, March 2, 2021 and March 2, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted share units were granted on March 2, 2018, with 2,941 vesting on each of March 2, 2019, March 2, 2020, March 2, 2021 and March 2, 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":11764,"derivative":{"underlying":"Ordinary Shares","underlying_shares":11764},"source":{"system":"sec-edgar","filing":"0001209191-18-054504","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118054504/doc4.xml","form_type":"4"}},{"id":3795480,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":150481,"kind":"person","name":"Griffin Deborah A","position":1,"cik":"0001719115","reported_name":"Griffin Deborah A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Options (right to buy)","published_at":"2018-10-09T20:06:34.000Z","date":"2018-03-02","kind":"grant","acquired":true,"shares":30002,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options were granted on March 2, 2018, with 7,500 vesting on each of March 2, 2019, March 2, 2020 and March 2, 2021 and 7,502 vesting on March 2, 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":30002,"derivative":{"exercise_price":19.16,"expiration_date":"2028-03-02","underlying":"Ordinary Shares","underlying_shares":30002},"source":{"system":"sec-edgar","filing":"0001209191-18-054504","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118054504/doc4.xml","form_type":"4"}},{"id":3811099,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":150481,"kind":"person","name":"Griffin Deborah A","position":1,"cik":"0001719115","reported_name":"Griffin Deborah A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Share Units","published_at":"2018-09-20T20:08:07.000Z","date":"2018-09-18","kind":"exercise","acquired":false,"shares":2376,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted share units were granted on September 18, 2017, with 2,376 vesting on each of September 18, 2018 and September 18, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted share units were granted on September 18, 2017, with 2,376 vesting on each of September 18, 2018 and September 18, 2019."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":2376,"derivative":{"underlying":"Ordinary Shares","underlying_shares":2376},"source":{"system":"sec-edgar","filing":"0001209191-18-051775","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118051775/doc4.xml","form_type":"4"}},{"id":3811098,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":150481,"kind":"person","name":"Griffin Deborah A","position":1,"cik":"0001719115","reported_name":"Griffin Deborah A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2018-09-20T20:08:07.000Z","date":"2018-09-18","kind":"sale","acquired":false,"shares":2376,"price":23.707,"value":56327.832,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.640 to $23.735, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-18-051775","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118051775/doc4.xml","form_type":"4"}},{"id":3811097,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":150481,"kind":"person","name":"Griffin Deborah A","position":1,"cik":"0001719115","reported_name":"Griffin Deborah A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2018-09-20T20:08:07.000Z","date":"2018-09-18","kind":"exercise","acquired":true,"shares":2376,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":2376,"source":{"system":"sec-edgar","filing":"0001209191-18-051775","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118051775/doc4.xml","form_type":"4"}},{"id":3988464,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":150481,"kind":"person","name":"Griffin Deborah A","position":1,"cik":"0001719115","reported_name":"Griffin Deborah A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Share Units","published_at":"2018-03-20T20:08:51.000Z","date":"2018-03-17","kind":"exercise","acquired":false,"shares":943,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted share units were granted on March 17, 2016, with 943 vesting on each of March 17, 2018 and March 17, 2019 and 944 vesting on March 17, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted share units were granted on March 17, 2016, with 943 vesting on each of March 17, 2018 and March 17, 2019 and 944 vesting on March 17, 2020."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":1887,"derivative":{"underlying":"Ordinary Shares","underlying_shares":943},"source":{"system":"sec-edgar","filing":"0001209191-18-020860","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118020860/doc4.xml","form_type":"4"}},{"id":3988463,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":150481,"kind":"person","name":"Griffin Deborah A","position":1,"cik":"0001719115","reported_name":"Griffin Deborah A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2018-03-20T20:08:51.000Z","date":"2018-03-19","kind":"sale","acquired":false,"shares":943,"price":17.878,"value":16858.954,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.83 to $17.925, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-18-020860","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118020860/doc4.xml","form_type":"4"}},{"id":3988462,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":150481,"kind":"person","name":"Griffin Deborah A","position":1,"cik":"0001719115","reported_name":"Griffin Deborah A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2018-03-20T20:08:51.000Z","date":"2018-03-17","kind":"exercise","acquired":true,"shares":943,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":943,"source":{"system":"sec-edgar","filing":"0001209191-18-020860","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118020860/doc4.xml","form_type":"4"}},{"id":3997146,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":150481,"kind":"person","name":"Griffin Deborah A","position":1,"cik":"0001719115","reported_name":"Griffin Deborah A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Share Units","published_at":"2018-03-14T20:29:39.000Z","date":"2018-03-12","kind":"exercise","acquired":false,"shares":952,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted share units were granted on March 12, 2015, with 952 vesting on March 12, 2018 and 953 vesting on March 12, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted share units were granted on March 12, 2015, with 952 vesting on March 12, 2018 and 953 vesting on March 12, 2019."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":953,"derivative":{"underlying":"Ordinary Shares","underlying_shares":952},"source":{"system":"sec-edgar","filing":"0001209191-18-019563","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118019563/doc4.xml","form_type":"4"}},{"id":3997145,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":150481,"kind":"person","name":"Griffin Deborah A","position":1,"cik":"0001719115","reported_name":"Griffin Deborah A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2018-03-14T20:29:39.000Z","date":"2018-03-12","kind":"sale","acquired":false,"shares":952,"price":19.489,"value":18553.528,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.46 to $19.50, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-18-019563","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118019563/doc4.xml","form_type":"4"}},{"id":3997144,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":150481,"kind":"person","name":"Griffin Deborah A","position":1,"cik":"0001719115","reported_name":"Griffin Deborah A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2018-03-14T20:29:39.000Z","date":"2018-03-12","kind":"exercise","acquired":true,"shares":952,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":952,"source":{"system":"sec-edgar","filing":"0001209191-18-019563","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118019563/doc4.xml","form_type":"4"}},{"id":4012712,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":150481,"kind":"person","name":"Griffin Deborah A","position":1,"cik":"0001719115","reported_name":"Griffin Deborah A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Share Units","published_at":"2018-03-06T21:14:00.000Z","date":"2018-03-03","kind":"exercise","acquired":false,"shares":1166,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on March 3, 2017, with 1,166 vesting on each of March 3, 2018, March 3, 2019, March 3, 2020 and March 3, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on March 3, 2017, with 1,166 vesting on each of March 3, 2018, March 3, 2019, March 3, 2020 and March 3, 2021."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":3498,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1166},"source":{"system":"sec-edgar","filing":"0001209191-18-017210","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118017210/doc4.xml","form_type":"4"}},{"id":4012711,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":150481,"kind":"person","name":"Griffin Deborah A","position":1,"cik":"0001719115","reported_name":"Griffin Deborah A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2018-03-06T21:14:00.000Z","date":"2018-03-05","kind":"sale","acquired":false,"shares":773,"price":19.38,"value":14980.74,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-18-017210","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118017210/doc4.xml","form_type":"4"}},{"id":4012710,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":150481,"kind":"person","name":"Griffin Deborah A","position":1,"cik":"0001719115","reported_name":"Griffin Deborah A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2018-03-06T21:14:00.000Z","date":"2018-03-05","kind":"tax_withholding","acquired":false,"shares":393,"price":19.38,"value":7616.34,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":773,"source":{"system":"sec-edgar","filing":"0001209191-18-017210","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118017210/doc4.xml","form_type":"4"}},{"id":4012709,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":150481,"kind":"person","name":"Griffin Deborah A","position":1,"cik":"0001719115","reported_name":"Griffin Deborah A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2018-03-06T21:14:00.000Z","date":"2018-03-03","kind":"exercise","acquired":true,"shares":1166,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":1166,"source":{"system":"sec-edgar","filing":"0001209191-18-017210","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118017210/doc4.xml","form_type":"4"}}]}